statistiche ricercatore

Nome	#
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma	283
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors	248
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies	243
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy	243
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer	242
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing	237
Tumor Stroma Manipulation By MSC	210
Surrounding pancreatic adenocarcinoma by killer mesenchymal stromal/stem cells	191
Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come?	161
GD2 CAR T cells against human glioblastoma	145
Staminali per la cura del tumore del pancreas: tra evidenze scienti che e possibile trasferimento clinico	127
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma	124
A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors	79
Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine	56
Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo	42
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma	36
Implantable and Bioresorbable Nanostructured Fluorescence Sensor for In vivo pH Monitoring	13
Totale	2.680

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	125	0	0	0	0	0	0	0	0	0	0	64	61
2019/2020	475	35	22	12	38	41	72	102	55	42	19	27	10
2020/2021	601	40	26	35	109	64	57	23	47	27	84	54	35
2021/2022	512	14	58	33	20	26	31	64	38	40	36	96	56
2022/2023	513	57	59	33	53	69	54	12	50	69	6	35	16
2023/2024	254	33	14	27	31	40	37	19	28	10	15	0	0
Totale													2.680